Hệ vi sinh vật đường ruột: yếu tố quan trọng ảnh hưởng đến điều trị bệnh bạch cầu lymphoblastic cấp tính ở trẻ em

Hunger SP, Mullighan CG (2015) Acute lymphoblastic leukemia in children. N Engl J Med 373:1541–1552. https://doi.org/10.1056/NEJMra1400972 Torpy JM, Lynm C, Glass RM (2009) JAMA patient page. Acute lymphoblastic leukemia. JAMA 301:452. https://doi.org/10.1001/jama.301.4.452 Dzutsev A, Goldszmid RS, Viaud S et al (2015) The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. Eur J Immunol 45:17–31. https://doi.org/10.1002/eji.201444972 De Santis S, Cavalcanti E, Mastronardi M et al (2015) Nutritional keys for intestinal barrier modulation. Front Immunol 6:612. https://doi.org/10.3389/fimmu.2015.00612 Li W, Deng Y, Chu Q, Zhang P (2019) Gut microbiome and cancer immunotherapy. Cancer Lett 447:41–47. https://doi.org/10.1016/j.canlet.2019.01.015 Baugh CW, Wang TJ, Caterino JM et al (2017) Emergency department management of patients with febrile neutropenia: guideline concordant or overly aggressive? Acad Emerg Med 24:83–91. https://doi.org/10.1111/acem.13079 Derrien M, Alvarez A-S, de Vos WM (2019) The gut microbiota in the first decade of life. Trends Microbiol 27:997–1010. https://doi.org/10.1016/j.tim.2019.08.001 Sims TT, El Alam MB, Karpinets TV et al (2021) Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Commun Biol 4:237. https://doi.org/10.1038/s42003-021-01741-x Liu X, Zou Y, Ruan M et al (2020) Pediatric acute lymphoblastic leukemia patients exhibit distinctive alterations in the gut microbiota. Front Cell Infect Microbiol 10:558799. https://doi.org/10.3389/fcimb.2020.558799 Chua LL, Rajasuriar R, Lim YAL et al (2020) Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy. BMC Cancer 20:151. https://doi.org/10.1186/s12885-020-6654-5 Wang Y, Xue J, Zhou X et al (2014) Oral microbiota distinguishes acute lymphoblastic leukemia pediatric hosts from healthy populations. PLoS ONE 9:e102116. https://doi.org/10.1371/journal.pone.0102116 Rajagopala SV, Singh H, Yu Y et al (2020) Persistent gut microbial dysbiosis in children with acute lymphoblastic leukemia (ALL) during chemotherapy. Microb Ecol 79:1034–1043. https://doi.org/10.1007/s00248-019-01448-x Thomas R, Wong WSW, Saadon R et al (2020) Gut microbial composition difference between pediatric ALL survivors and siblings. Pediatr Hematol Oncol 37:475–488. https://doi.org/10.1080/08880018.2020.1759740 Hakim H, Dallas R, Wolf J et al (2018) Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia. Clin Infect Dis 67:541–548. https://doi.org/10.1093/cid/ciy153 Chua LL, Rajasuriar R, Azanan MS et al (2017) Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation. Microbiome 5:35. https://doi.org/10.1186/s40168-017-0250-1 Huang Y, Yang W, Liu H et al (2012) Effect of high-dose methotrexate chemotherapy on intestinal Bifidobacteria, Lactobacillus and Escherichia coli in children with acute lymphoblastic leukemia. Exp Biol Med (Maywood) 237:305–311. https://doi.org/10.1258/ebm.2011.011297 De Pietri S, Ingham AC, Frandsen TL et al (2020) Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: the impact of the gut microbiota. Int J Cancer 147:1953–1962. https://doi.org/10.1002/ijc.32942 Javed F, Utreja A, Bello Correa FO et al (2012) Oral health status in children with acute lymphoblastic leukemia. Crit Rev Oncol Hematol 83:303–309. https://doi.org/10.1016/j.critrevonc.2011.11.003 Sherborne AL, Hemminki K, Kumar R et al (2011) Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia. Haematologica 96:1049–1054. https://doi.org/10.3324/haematol.2011.040121 Tasian SK, Loh ML, Hunger SP (2015) Childhood acute lymphoblastic leukemia: integrating genomics into therapy. Cancer 121:3577–3590. https://doi.org/10.1002/cncr.29573 Vicente-Dueñas C, Janssen S, Oldenburg M et al (2020) An intact gut microbiome protects genetically predisposed mice against leukemia. Blood 136:2003–2017. https://doi.org/10.1182/blood.2019004381 Wakabayashi K, Yano S, Kadowaki T et al (2012) Pulmonary actinomycosis caused by Actinomyces cardiffensis. Intern Med 51:2929–2931. https://doi.org/10.2169/internalmedicine.51.7997 Kushnareva MV, Keshishyan ES, Balashova ED (2019) The etiology of neonatal pneumonia, complicated by bronchopulmonary dysplasia. J Neonatal Perinatal Med 12:429–436. https://doi.org/10.3233/NPM-17159 Dixon SB, Chen Y, Yasui Y et al (2022) Impact of risk-stratified therapy on health status in survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev 31:150–160. https://doi.org/10.1158/1055-9965.EPI-21-0667 Robison LL, Hudson MM (2014) Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer 14:61–70. https://doi.org/10.1038/nrc3634 Sági V, Makra N, Csoszánszki N et al (2022) The influence of the gut microbiome in paediatric cancer origin and treatment. Antibiotics (Basel) 11:1521. https://doi.org/10.3390/antibiotics11111521 Oldenburg M, Rüchel N, Janssen S et al (2021) The microbiome in childhood acute lymphoblastic leukemia. Cancers 13:4947. https://doi.org/10.3390/cancers13194947 Lähteenmäki K, Wacklin P, Taskinen M et al (2017) Haematopoietic stem cell transplantation induces severe dysbiosis in intestinal microbiota of paediatric ALL patients. Bone Marrow Transplant 52:1479–1482. https://doi.org/10.1038/bmt.2017.168 Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354:1813–1826. https://doi.org/10.1056/NEJMra052638 Schwabkey ZI, Jenq RR (2020) Microbiome anomalies in allogeneic hematopoietic cell transplantation. Annu Rev Med 71:137–148. https://doi.org/10.1146/annurev-med-052918-122440 Liu X, Zou Y, Zhang Y et al (2021) Characteristics in gut microbiome is associated with chemotherapy-induced pneumonia in pediatric acute lymphoblastic leukemia. BMC Cancer 21:1190. https://doi.org/10.1186/s12885-021-08917-y Dunn KA, Connors J, Bielawski JP et al (2021) Investigating the gut microbial community and genes in children with differing levels of change in serum asparaginase activity during pegaspargase treatment for acute lymphoblastic leukemia. Leuk Lymphoma 62:927–936. https://doi.org/10.1080/10428194.2020.1850718 Jing D, Hua L, Wu Y et al (2018) Study on intestinal bacterial flora by fluorescent quantitative PCR in children with acute lymphoblastic leukemia of high-dose methotrexate therapy. Chinese Journal of Microecology 20:197–202 Song Y, Gyarmati P (2019) Bacterial translocation in acute lymphocytic leukemia. PLoS ONE 14:e0214526. https://doi.org/10.1371/journal.pone.0214526 Bai L, Zhou P, Li D, Ju X (2017) Changes in the gastrointestinal microbiota of children with acute lymphoblastic leukaemia and its association with antibiotics in the short term. J Med Microbiol 66:1297–1307. https://doi.org/10.1099/jmm.0.000568 Wolf J, Tang L, Flynn PM et al (2017) Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia. Clin Infect Dis 65:1790–1798. https://doi.org/10.1093/cid/cix644 Simona Z, Ondřej H, Jana P et al (2018) Occurrence and antibiotic resistance of Enterobacteriaceae in acute leukemia patients. Klin Onkol 31:282–288. https://doi.org/10.14735/amko2018282 Dunn KA, MacDonald T, Rodrigues GJ et al (2022) Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria responsible for activities that enhance colonic defense. Front Cell Infect Microbiol 12:924707. https://doi.org/10.3389/fcimb.2022.924707 Ugrayová S, Švec P, Hric I et al (2022) Gut microbiome suffers from hematopoietic stem cell transplantation in childhood and its characteristics are positively associated with intra-hospital physical exercise. Biology (Basel) 11:785. https://doi.org/10.3390/biology11050785 Onciu M (2009) Acute lymphoblastic leukemia. Hematol Oncol Clin North Am 23:655–674. https://doi.org/10.1016/j.hoc.2009.04.009 Pui C-H, Evans WE (2006) Treatment of acute lymphoblastic leukemia. N Engl J Med 354:166–178. https://doi.org/10.1056/NEJMra052603 Sly LM (2020) Gut microbes in pediatric ALL survivorship. Pediatr Hematol Oncol 37:451–454. https://doi.org/10.1080/08880018.2020.1793850 Graziani F, Pujol A, Nicoletti C et al (2016) Ruminococcus gnavus E1 modulates mucin expression and intestinal glycosylation. J Appl Microbiol 120:1403–1417. https://doi.org/10.1111/jam.13095 Lucafò M, Franzin M, Lagatolla C et al (2020) Emerging insights on the interaction between anticancer and immunosuppressant drugs and intestinal microbiota in pediatric patients. Clin Transl Sci 13:238–259. https://doi.org/10.1111/cts.12722 Maier L, Pruteanu M, Kuhn M et al (2018) Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555:623–628. https://doi.org/10.1038/nature25979 Asselin B, Rizzari C (2015) Asparaginase pharmacokinetics and implications of therapeutic drug monitoring. Leuk Lymphoma 56:2273–2280. https://doi.org/10.3109/10428194.2014.1003056 Story MD, Voehringer DW, Stephens LC, Meyn RE (1993) L-asparaginase kills lymphoma cells by apoptosis. Cancer Chemother Pharmacol 32:129–133. https://doi.org/10.1007/BF00685615 Toksvang LN, Lee SHR, Yang JJ, Schmiegelow K (2022) Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations. Leukemia 36:1749–1758. https://doi.org/10.1038/s41375-022-01591-4 Teuffel O, Kuster SP, Hunger SP et al (2011) Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia 25:1232–1238. https://doi.org/10.1038/leu.2011.84 Franzin M, Stefančič K, Lucafò M et al (2021) Microbiota and drug response in inflammatory bowel disease. Pathogens 10:211. https://doi.org/10.3390/pathogens10020211 Ruiz L, Delgado S, Ruas-Madiedo P et al (2017) Bifidobacteria and their molecular communication with the immune system. Front Microbiol 8:2345. https://doi.org/10.3389/fmicb.2017.02345 Ding Y-H, Qian L-Y, Pang J et al (2017) The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy. Oncotarget 8:59915–59928. https://doi.org/10.18632/oncotarget.18346 Yang W, Cai J, Shen S et al (2021) Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial. Lancet Oncol 22:1322–1332. https://doi.org/10.1016/S1470-2045(21)00328-4 Ns P, Yt C, Jo G et al (2020) Neuroanatomical abnormalities related to dexamethasone exposure in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 67:e27968. https://doi.org/10.1002/pbc.27968 Chandran P, Satthaporn S, Robins A, Eremin O (2003) Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I). Surgeon 1:63–75. https://doi.org/10.1016/s1479-666x(03)80118-x Hu Y, Feng Y, Wu J et al (2019) The gut microbiome signatures discriminate healthy from pulmonary tuberculosis patients. Front Cell Infect Microbiol 9:90. https://doi.org/10.3389/fcimb.2019.00090 He Y, Wen Q, Yao F et al (2017) Gut-lung axis: the microbial contributions and clinical implications. Crit Rev Microbiol 43:81–95. https://doi.org/10.1080/1040841X.2016.1176988 Garcia JB, Lei X, Wierda W et al (2013) Pneumonia during remission induction chemotherapy in patients with acute leukemia. Ann Am Thorac Soc 10:432–440. https://doi.org/10.1513/AnnalsATS.201304-097OC Schoener CA, Carillo-Conde B, Hutson HN, Peppas NA (2013) An inulin and doxorubicin conjugate for improving cancer therapy. J Drug Deliv Sci Technol 23:111–118. https://doi.org/10.1016/s1773-2247(13)50018-9 Reyna-Figueroa J, Barrón-Calvillo E, García-Parra C et al (2019) Probiotic supplementation decreases chemotherapy-induced gastrointestinal side effects in patients with acute leukemia. J Pediatr Hematol Oncol 41:468–472. https://doi.org/10.1097/MPH.0000000000001497 Reyna-Figueroa J, Bejarano-Juvera AA, García-Parra C et al (2021) Decrease of postchemotherapy complications with the use of probiotics in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 43:e457–e461. https://doi.org/10.1097/MPH.0000000000001956 Yang Y, Xia Y, Chen H et al (2016) The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial. Oncotarget 7:8432–8440. https://doi.org/10.18632/oncotarget.7045 Kotzampassi K, Stavrou G, Damoraki G et al (2015) A four-probiotics regimen reduces postoperative complications after colorectal surgery: a randomized, double-blind, placebo-controlled study. World J Surg 39:2776–2783. https://doi.org/10.1007/s00268-015-3071-z Dabard J, Bridonneau C, Phillipe C et al (2001) Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl Environ Microbiol 67:4111–4118. https://doi.org/10.1128/AEM.67.9.4111-4118.2001 Miquel S, Martín R, Rossi O et al (2013) Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol 16:255–261. https://doi.org/10.1016/j.mib.2013.06.003 Edgar RC (2013) UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10:996–998. https://doi.org/10.1038/nmeth.2604 Frank DN, St Amand AL, Feldman RA et al (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104:13780–13785. https://doi.org/10.1073/pnas.0706625104 Alexander S, Fisher BT, Gaur AH et al (2018) Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial. JAMA 320:995–1004. https://doi.org/10.1001/jama.2018.12512 Tunyapanit W, Chelae S, Laoprasopwattana K (2018) Does ciprofloxacin prophylaxis during chemotherapy induce intestinal microflora resistance to ceftazidime in children with cancer? J Infect Chemother 24:358–362. https://doi.org/10.1016/j.jiac.2017.12.012 Brown PA, Shah B, Advani A et al (2021) Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19:1079–1109. https://doi.org/10.6004/jnccn.2021.0042 Zhang X, Chen J, Han M-Z et al (2021) The consensus from the Chinese Society of hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol 14:145. https://doi.org/10.1186/s13045-021-01159-2 Yanir AD, Martinez CA, Sasa G et al (2018) Current allogeneic hematopoietic stem cell transplantation for pediatric acute lymphocytic leukemia: success, failure and future perspectives-a single-center experience, 2008 to 2016. Biol Blood Marrow Transplant 24:1424–1431. https://doi.org/10.1016/j.bbmt.2018.03.001 Dalle J-H, Balduzzi A, Bader P et al (2018) Allogeneic stem cell transplantation from HLA-mismatched donors for pediatric patients with acute lymphoblastic leukemia treated according to the 2003 BFM and 2007 international BFM studies: impact of disease risk on outcomes. Biol Blood Marrow Transplant 24:1848–1855. https://doi.org/10.1016/j.bbmt.2018.05.009 Masetti R, Muratore E, Gori D et al (2022) Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis. Ann Hematol 101:2497–2506. https://doi.org/10.1007/s00277-022-04965-x Peled JU, Gomes ALC, Devlin SM et al (2020) Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N Engl J Med 382:822–834. https://doi.org/10.1056/NEJMoa1900623 Shono Y, van den Brink MRM (2018) Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer 18:283–295. https://doi.org/10.1038/nrc.2018.10 Okamoto Y, Nakazawa Y, Inoue M et al (2020) Hematopoietic stem cell transplantation in children and adolescents with nonremission acute lymphoblastic leukemia. Pediatr Blood Cancer 67:e28732. https://doi.org/10.1002/pbc.28732 Liu C, Frank DN, Horch M et al (2017) Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors. Bone Marrow Transplant 52:1643–1650. https://doi.org/10.1038/bmt.2017.200 Taur Y, Jenq RR, Perales M-A et al (2014) The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 124:1174–1182. https://doi.org/10.1182/blood-2014-02-554725 Taur Y, Xavier JB, Lipuma L et al (2012) Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55:905–914. https://doi.org/10.1093/cid/cis580 Noor F, Kaysen A, Wilmes P, Schneider JG (2019) The gut microbiota and hematopoietic stem cell transplantation: challenges and potentials. J Innate Immun 11:405–415. https://doi.org/10.1159/000492943 Toubai T, Mathewson ND, Magenau J, Reddy P (2016) Danger signals and graft-versus-host disease: current understanding and future perspectives. Front Immunol 7:539. https://doi.org/10.3389/fimmu.2016.00539 Simms-Waldrip TR, Sunkersett G, Coughlin LA et al (2017) Antibiotic-induced depletion of anti-inflammatory clostridia is associated with the development of graft-versus-host disease in pediatric stem cell transplantation patients. Biol Blood Marrow Transplant 23:820–829. https://doi.org/10.1016/j.bbmt.2017.02.004 Fujimaki K, Maruta A, Yoshida M et al (2001) Immune reconstitution assessed during five years after allogeneic bone marrow transplantation. Bone Marrow Transplant 27:1275–1281. https://doi.org/10.1038/sj.bmt.1703056 Ingham AC, Kielsen K, Cilieborg MS et al (2019) Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation. Microbiome 7:131. https://doi.org/10.1186/s40168-019-0745-z Muratore E, Leardini D, Baccelli F et al (2022) Nutritional modulation of the gut microbiome in allogeneic hematopoietic stem cell transplantation recipients. Front Nutr 9:993668. https://doi.org/10.3389/fnut.2022.993668 D’Amico F, Biagi E, Rampelli S et al (2019) Enteral nutrition in pediatric patients undergoing hematopoietic SCT promotes the recovery of gut microbiome homeostasis. Nutrients 11:E2958. https://doi.org/10.3390/nu11122958 Iyama S, Sato T, Tatsumi H et al (2014) Efficacy of enteral supplementation enriched with glutamine, fiber, and oligosaccharide on mucosal injury following hematopoietic stem cell transplantation. Case Rep Oncol 7:692–699. https://doi.org/10.1159/000368714 Andermann TM, Peled JU, Ho C et al (2018) The microbiome and hematopoietic cell transplantation: past, present, and future. Biol Blood Marrow Transplant 24:1322–1340. https://doi.org/10.1016/j.bbmt.2018.02.009 Gupta S, Allen-Vercoe E, Petrof EO (2016) Fecal microbiota transplantation: in perspective. Ther Adv Gastroenterol 9:229–239. https://doi.org/10.1177/1756283X15607414 Severyn CJ, Brewster R, Andermann TM (2019) Microbiota modification in hematology: still at the bench or ready for the bedside? Hematology 2019:303–314. https://doi.org/10.1182/hematology.2019000365 Merli P, Putignani L, Ruggeri A et al (2020) Decolonization of multi-drug resistant bacteria by fecal microbiota transplantation in five pediatric patients before allogeneic hematopoietic stem cell transplantation: gut microbiota profiling, infectious and clinical outcomes. Haematologica 105:2686–2690. https://doi.org/10.3324/haematol.2019.244210